Dihydroquercetin (DHQ) ameliorates LPS-induced acute lung injury by regulating macrophage M2 polarization through IRF4/miR-132-3p/FBXW7 axis

IF 3.3 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Chen Li, Jianhua Liu, Changhong Zhang, Liang Cao, Fang Zou, Zhihua Zhang
{"title":"Dihydroquercetin (DHQ) ameliorates LPS-induced acute lung injury by regulating macrophage M2 polarization through IRF4/miR-132-3p/FBXW7 axis","authors":"Chen Li,&nbsp;Jianhua Liu,&nbsp;Changhong Zhang,&nbsp;Liang Cao,&nbsp;Fang Zou,&nbsp;Zhihua Zhang","doi":"10.1016/j.pupt.2023.102249","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><span>Acute lung injury (ALI) is a common complication of </span>sepsis<span>. Dihydroquercetin (DHQ) has been found to attenuate lipopolysaccharide (LPS)-induced inflammation. However, the effect of DHQ on LPS-challenged ALI remains unclear.</span></p></div><div><h3>Methods</h3><p><span>Pulmonary HE and TUNEL staining<span><span> and lung wet/dry ratio were detected in LPS-treated Balb/c mice. IL-1β, IL-6 and TNF-α levels were determined utilizing ELISA assay. RAW264.7 cell </span>apoptosis<span><span> and macrophage markers (CD86, CD206) were tested using flow cytometry. TC-1 viability was analyzed by MTT assay. </span>Western blot<span><span> measured protein expression of macrophage markers. Interactions of miR-132–3p, </span>IRF4 and FBXW7 were explored utilizing </span></span></span></span>ChIP<span>, RNA pull-down and dual luciferase reporter assays.</span></p></div><div><h3>Results</h3><p>DHQ alleviated histopathological change, pulmonary edema<span><span> and apoptosis in LPS-treated mice. DHQ affected LPS-induced M2 macrophage polarization<span> and TC-1 cell injury-related indicators, such as decreased cell activity, decreased LDH levels, and increased apoptosis. </span></span>LPS inhibited IRF4 and miR-132–3p expression, activated Notch pathway and increased FBXW7 level, which were overturned by DHQ. IRF4 transcriptionally activated miR-132–3p expression. FBXW7 was a downstream target of miR-132–3p.</span></p></div><div><h3>Conclusion</h3><p>DHQ alleviated LPS-induced lung injury through promoting macrophage M2 polarization via IRF4/miR-132–3p/FBXW7 axis, which provides a new therapeutic strategy for ALI.</p></div>","PeriodicalId":20799,"journal":{"name":"Pulmonary pharmacology & therapeutics","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary pharmacology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094553923000615","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Background

Acute lung injury (ALI) is a common complication of sepsis. Dihydroquercetin (DHQ) has been found to attenuate lipopolysaccharide (LPS)-induced inflammation. However, the effect of DHQ on LPS-challenged ALI remains unclear.

Methods

Pulmonary HE and TUNEL staining and lung wet/dry ratio were detected in LPS-treated Balb/c mice. IL-1β, IL-6 and TNF-α levels were determined utilizing ELISA assay. RAW264.7 cell apoptosis and macrophage markers (CD86, CD206) were tested using flow cytometry. TC-1 viability was analyzed by MTT assay. Western blot measured protein expression of macrophage markers. Interactions of miR-132–3p, IRF4 and FBXW7 were explored utilizing ChIP, RNA pull-down and dual luciferase reporter assays.

Results

DHQ alleviated histopathological change, pulmonary edema and apoptosis in LPS-treated mice. DHQ affected LPS-induced M2 macrophage polarization and TC-1 cell injury-related indicators, such as decreased cell activity, decreased LDH levels, and increased apoptosis. LPS inhibited IRF4 and miR-132–3p expression, activated Notch pathway and increased FBXW7 level, which were overturned by DHQ. IRF4 transcriptionally activated miR-132–3p expression. FBXW7 was a downstream target of miR-132–3p.

Conclusion

DHQ alleviated LPS-induced lung injury through promoting macrophage M2 polarization via IRF4/miR-132–3p/FBXW7 axis, which provides a new therapeutic strategy for ALI.

双氢槲皮素(DHQ)通过IRF4/miR-132-3p/FBXW7轴调节巨噬细胞M2极化,改善lps诱导的急性肺损伤
背景:急性肺损伤(ALI)是脓毒症的常见并发症。双氢槲皮素(DHQ)已被发现可以减轻脂多糖(LPS)诱导的炎症。然而,DHQ对lps挑战性ALI的影响尚不清楚。方法检测lps处理Balb/c小鼠肺HE、TUNEL染色及肺干湿比。ELISA法检测各组IL-1β、IL-6、TNF-α水平。流式细胞术检测RAW264.7细胞凋亡和巨噬细胞标志物(CD86、CD206)。MTT法检测TC-1细胞活力。Western blot检测巨噬细胞标志物蛋白表达。利用ChIP、RNA pull-down和双荧光素酶报告基因检测探索miR-132-3p、IRF4和FBXW7的相互作用。结果dhq可减轻lps处理小鼠的组织病理改变、肺水肿和细胞凋亡。DHQ影响lps诱导的M2巨噬细胞极化和TC-1细胞损伤相关指标,如细胞活性降低、LDH水平降低、凋亡增加。LPS抑制IRF4和miR-132-3p的表达,激活Notch通路,升高FBXW7水平,DHQ逆转了这一作用。IRF4转录激活miR-132-3p表达。FBXW7是miR-132-3p的下游靶点。结论dhq通过IRF4/ miR-132-3p /FBXW7轴促进巨噬细胞M2极化,减轻lps诱导的肺损伤,为ALI提供了新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
41
审稿时长
42 days
期刊介绍: Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews. Research Areas Include: • All major diseases of the lung • Physiology • Pathology • Drug delivery • Metabolism • Pulmonary Toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信